Drug intelligence / Profile preview

AuNP-BBN-Pt2

Development stage
Preclinical
Lead developer
Universidade de Lisboa
Modality
Nanoparticles → Drug Delivery Systems, Peptides, Small Molecules
Administration
Intratumoral
01

Overview

**AuNP-BBN-Pt2** is a preclinical, gastrin-releasing peptide receptor-targeted gold-nanoparticle nanomedicine designed for prostate-cancer theranostics. It comprises a small gold nanoparticle functionalized with a DOTA derivative, the GRPR-targeting bombesin analog BBN[7-14], and a cisplatin-derived Pt(IV) prodrug connected through a PEGylated linker. The bombesin ligand promotes uptake by GRPR-positive tumor cells, while intracellular reduction of the Pt(IV) prodrug is intended to generate cytotoxic Pt(II) species that form DNA lesions. A related gallium-67-labeled derivative was investigated for SPECT-compatible imaging, but AuNP-BBN-Pt2 itself is the non-radiolabeled nanoparticle construct. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/36593794/))

Other names
AuNP-BBN-Pt2AuNP-BBN-Pt-2AuNP-BBN-Pt 2gold nanoparticle + bombesin + Pt2
02

Targets

DNAGRPR (Gastrin-releasing peptide receptor)

Beyond the preview

Go deeper on AuNP-BBN-Pt2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AuNP-BBN-Pt2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call